Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s medical cannabis oral solution THC25 across the country.

Denise Faltischek, Tilray’s chief strategy officer and head of international business, stated, “Expanding our approved authorization into Italy once again proves our commitment to be the most responsible, trusted and market leading cannabis company …

Full story available on Benzinga.com